Cytotoxicity of the novel glutathione-activated thiopurine prodrugs cis-AVTP [cis-6-(2-acetylvinylthio)purine] and trans-AVTG [trans-6-(2-acetylvinylthio)guanine] results from the National Cancer Institute's anticancer drug screen (Q40587148)
Jump to navigation
Jump to search
scientific article published on March 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Cytotoxicity of the novel glutathione-activated thiopurine prodrugs cis-AVTP [cis-6-(2-acetylvinylthio)purine] and trans-AVTG [trans-6-(2-acetylvinylthio)guanine] results from the National Cancer Institute's anticancer drug screen |
scientific article published on March 2004 |
Statements
1 reference
Cytotoxicity of the novel glutathione-activated thiopurine prodrugs cis-AVTP [cis-6-(2-acetylvinylthio)purine] and trans-AVTG [trans-6-(2-acetylvinylthio)guanine] results from the National Cancer Institute's anticancer drug screen (English)
1 reference
Sjofn Gunnarsdottir
1 reference
Adnan A Elfarra
1 reference
1 March 2004
1 reference
1 reference
32
1 reference
3
1 reference
321-327
1 reference
Identifiers
1 reference
1 reference